Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.
<h4>Background</h4>Atypical antipsychotic medications are widely prescribed for the adjunctive treatment of depression, yet their total risk-benefit profile is not well understood. We thus conducted a systematic review of the efficacy and safety profiles of atypical antipsychotic medicat...
Enregistré dans:
Auteurs principaux: | Glen I Spielmans, Margit I Berman, Eftihia Linardatos, Nicholas Z Rosenlicht, Angela Perry, Alexander C Tsai |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7ffe1f0191a34caca1e30bed0cee47d9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Atypical antipsychotics as add-on treatment in late-life depression
par: Cakir S, et autres
Publié: (2016) -
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
par: Luan SX, et autres
Publié: (2018) -
Atypical depression: current perspectives
par: Łojko D, et autres
Publié: (2017) -
Atypical antipsychotics in the treatment of early-onset schizophrenia
par: Hrdlicka M, et autres
Publié: (2015) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
par: Gabriel A
Publié: (2013)